Literature DB >> 32035322

Intelligently thermoresponsive flower-like hollow nano-ruthenium system for sustained release of nerve growth factor to inhibit hyperphosphorylation of tau and neuronal damage for the treatment of Alzheimer's disease.

Hui Zhou1, Youcong Gong1, Yanan Liu1, Anlian Huang1, Xufeng Zhu1, Jiawei Liu1, Guanglong Yuan1, Li Zhang2, Ji-An Wei2, Jie Liu3.   

Abstract

Alzheimer's disease (AD) seriously affects human health and life and lacks effective treatments. The lessons of many clinical trial failures suggest that targeting amyloid beta to treat AD is difficult, and finding new targets is an important direction for AD drug research. The neurofibrillary tangles formed by hyperphosphorylation of tau protein induce the production of cytotoxic reactive oxygen species (ROS) and cause neuronal apoptosis. Therefore, inhibition of hyperphosphorylation of tau protein and reduction of neuronal damage have become promising methods for the treatment of AD. We herein designed a novel nanocomposite with high stability and good biocompatibility by using flower-shaped hollow nano-ruthenium (Ru NPs) as a carrier, loading nerve growth factor (NGF) and sealing with phase change material (PCM). Due to its excellent photothermal effect, under the near-infrared (NIR) irradiation, the nanocomposite could effectively penetrate the blood-brain barrier (BBB) and respond to phase changes in the lesion area, releasing NGF, which inhibited tau hyperphosphorylation, reduced oxidative stress, and more importantly restored nerve damage and maintained neuronal morphology, thereby significantly improving learning and memory in AD mice. Thus, the experimental results indicate that multifunctional nanocomposites may be a promising drug in the treatment of AD.
Copyright © 2020 Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  Alzheimer's disease; Drug delivery; Nanocomposite; Nerve injury; Photothermal effect; Tauopathy

Mesh:

Substances:

Year:  2020        PMID: 32035322     DOI: 10.1016/j.biomaterials.2020.119822

Source DB:  PubMed          Journal:  Biomaterials        ISSN: 0142-9612            Impact factor:   12.479


  10 in total

Review 1.  Tau Toxicity in Neurodegeneration.

Authors:  Shu-Yu Liang; Zuo-Teng Wang; Lan Tan; Jin-Tai Yu
Journal:  Mol Neurobiol       Date:  2022-03-31       Impact factor: 5.682

2.  PINK1 overexpression prevents forskolin-induced tau hyperphosphorylation and oxidative stress in a rat model of Alzheimer's disease.

Authors:  Xiao-Juan Wang; Lin Qi; Ya-Fang Cheng; Xue-Fei Ji; Tian-Yan Chi; Peng Liu; Li-Bo Zou
Journal:  Acta Pharmacol Sin       Date:  2021-12-10       Impact factor: 7.169

Review 3.  Recent Advances in the Treatment of Alzheimer's Disease Using Nanoparticle-Based Drug Delivery Systems.

Authors:  Prashant Poudel; Soyeun Park
Journal:  Pharmaceutics       Date:  2022-04-11       Impact factor: 6.525

Review 4.  Surface Modification of Iron Oxide-Based Magnetic Nanoparticles for Cerebral Theranostics: Application and Prospection.

Authors:  Yanyue Wu; Zhiguo Lu; Yan Li; Jun Yang; Xin Zhang
Journal:  Nanomaterials (Basel)       Date:  2020-07-24       Impact factor: 5.076

5.  Nano-Honokiol ameliorates the cognitive deficits in TgCRND8 mice of Alzheimer's disease via inhibiting neuropathology and modulating gut microbiota.

Authors:  Chang Qu; Qiao-Ping Li; Zi-Ren Su; Siu-Po Ip; Qiu-Ju Yuan; You-Liang Xie; Qing-Qing Xu; Wen Yang; Yan-Feng Huang; Yan-Fang Xian; Zhi-Xiu Lin
Journal:  J Adv Res       Date:  2021-03-31       Impact factor: 10.479

Review 6.  Anti-Parkinsonian Therapy: Strategies for Crossing the Blood-Brain Barrier and Nano-Biological Effects of Nanomaterials.

Authors:  Guowang Cheng; Yujing Liu; Rui Ma; Guopan Cheng; Yucheng Guan; Xiaojia Chen; Zhenfeng Wu; Tongkai Chen
Journal:  Nanomicro Lett       Date:  2022-04-15

7.  "Drug-Carrier" Synergy Therapy for Amyloid-β Clearance and Inhibition of Tau Phosphorylation via Biomimetic Lipid Nanocomposite Assembly.

Authors:  Guochen Han; Kaiwen Bai; Xiaoyu Yang; Chenhua Sun; Yi Ji; Jianping Zhou; Huaqing Zhang; Yang Ding
Journal:  Adv Sci (Weinh)       Date:  2022-03-20       Impact factor: 17.521

8.  Ultrasmall Coordination Polymers for Alleviating ROS-Mediated Inflammatory and Realizing Neuroprotection against Parkinson's Disease.

Authors:  Guowang Cheng; Xueliang Liu; Yujing Liu; Yao Liu; Rui Ma; Jingshan Luo; Xinyi Zhou; Zhenfeng Wu; Zhuang Liu; Tongkai Chen; Yu Yang
Journal:  Research (Wash D C)       Date:  2022-07-18

9.  Brain-Targeted Biomimetic Nanodecoys with Neuroprotective Effects for Precise Therapy of Parkinson's Disease.

Authors:  Yao Liu; Jingshan Luo; Yujing Liu; Wen Liu; Guangtao Yu; Yuting Huang; Yu Yang; Xiaojia Chen; Tongkai Chen
Journal:  ACS Cent Sci       Date:  2022-09-13       Impact factor: 18.728

Review 10.  Nanotechnology-Based Drug Delivery Strategies to Repair the Mitochondrial Function in Neuroinflammatory and Neurodegenerative Diseases.

Authors:  Luis F González; Lorenzo E Bevilacqua; Rodrigo Naves
Journal:  Pharmaceutics       Date:  2021-12-01       Impact factor: 6.321

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.